PANCREATIC ADENOCARCINOMA NON-RESECTABLE

Clinical trials for PANCREATIC ADENOCARCINOMA NON-RESECTABLE explained in plain language.

Never miss a new study

Get alerted when new PANCREATIC ADENOCARCINOMA NON-RESECTABLE trials appear

Sign up with your email to follow new studies for PANCREATIC ADENOCARCINOMA NON-RESECTABLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Implantable device aims to target pancreatic tumors with fewer side effects

Disease control Recruiting now

This early-stage study is testing the safety of a new implantable device that delivers chemotherapy directly to pancreatic tumors. The device is placed on the pancreas during surgery and releases the drug gemcitabine locally, aiming to target the cancer more precisely and potenti…

Matched conditions: PANCREATIC ADENOCARCINOMA NON-RESECTABLE

Phase: PHASE1 • Sponsor: Continuity Biosciences, LLC • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

PANCREATIC ADENOCARCINOMA NON-RESECTABLE

Get alerted when new PANCREATIC ADENOCARCINOMA NON-RESECTABLE trials appear

Implantable device aims to target pancreatic tumors with fewer side effects